Ochoa, Augusto C. |
Lsu Health Sciences Center |
Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN) |
NCI Community Oncology Research Program, NCORP Minority Underserved |
RFA-CA-18-017: NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites |
Faller, Bryan |
Decatur Memorial Hospital |
Heartland Cancer Research NCORP |
NCI Community Oncology Research Program, NCORP Community Sites |
RFA-CA-18-016: NCI Community Oncology Research Program (NCORP) Community Sites |
Nelson, Christian J |
Sloan-Kettering Inst Can Research |
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery |
Supportive Care and Symptom Management, Sexual Health |
PA-13-302: Research Project Grant |
Peppone, Luke Joseph |
University Of Rochester |
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients |
|
PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program |
Visovsky, Constance G. |
University Of South Florida |
Home-Based Physical Activity Intervention for Taxane-Induced CIPN |
Supportive Care and Symptom Management, Neuropathy |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
Melemedjian, Ohannes Kevork |
University Of Maryland Baltimore |
Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy |
Supportive Care and Symptom Management, Neuropathy |
RFA-NS-18-043: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment |
Cole, Peter D |
Rutgers Biomedical And Health Sciences |
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL |
Supportive Care and Symptom Management, Pediatrics/Adolescents/Young Adult, Cognitive Dysfunction |
PAR-16-218: Research Answers to NCIs Pediatric Provocative Questions |
Plas, Ellen Van Der |
Arkansas Children'S Hospital Res Inst |
Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia |
Supportive Care and Symptom Management, Pediatrics/Adolescents/Young Adult, Cognitive Dysfunction |
PA-20-185: NIH Research Project Grant |
Infante, Rodney E |
Ut Southwestern Medical Center |
Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia |
Supportive Care and Symptom Management, Anorexia |
PA-20-185: NIH Research Project Grant |
Miaskowski, Christine A. |
University Of California, San Francisco |
Impact of Hearing Loss and Tinnitus in Cancer Survivors |
Supportive Care and Symptom Management, Other Supportive Care Issues |
PA-16-160: NIH Research Project Grant |
Hundley, William Gregory |
Wake Forest University Health Sciences |
Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment |
Supportive Care and Symptom Management, Quality of Life |
PAR-18-307: Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional) |
Bender, Catherine M. |
University Of Pittsburgh At Pittsburgh |
Influence of Exercise on Neurocognitive Function in Breast Cancer |
Supportive Care and Symptom Management, Cognitive Dysfunction |
PA-13-302: Research Project Grant |
Fortier, Michelle |
University Of California-Irvine |
Innovative Pain and Symptom Management Program for Children with Cancer |
Supportive Care and Symptom Management, Pain, Pediatrics/Adolescents/Young Adult |
PA-16-160: NIH Research Project Grant |
Abdi, Salahadin |
University Of Tx Md Anderson Can Ctr |
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults with Cancer: A two arm pilot study |
Supportive Care and Symptom Management, Neuropathy |
PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies |
Staff, Nathan P |
Mayo Clinic Rochester |
Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity |
Supportive Care and Symptom Management, Neuropathy |
PAR-21-329: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |